Sintilimab for Gastric Cancer, Lepodisiran Targeting Lipoprotein(a), CONSORT Extension for Factorial Trials, and more
- Author
- American Medical Association
- Published
- Tue 05 Dec 2023
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2023.13505
Editor’s Summary by Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for the December 5, 2023, issue. Related Content:
